• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Konferenzschrift
  4. Progenitor cells from the adipose tissue: Cell source for the construction of novel in vitro test systems?
 
  • Details
  • Full
Options
2007
Conference Paper
Title

Progenitor cells from the adipose tissue: Cell source for the construction of novel in vitro test systems?

Title Supplement
Abstract
Abstract
Background: Tissue engineering is based on the idea of cultivating cells on suitable matrices. Thereby tissues can be constructed which allows the analysis of different applications under in vitro conditions. Essential for their generation are vital and functional cells like primary cells, but they are often not available in an adequate amount. Therefore stem cells are used, which can be differentiated towards several cell types. Progenitor cells (PCs) from adipose tissue are a possible source. The advantages of these cells are: high availability, extraction by a biopsy, human/autologous material. Methods: The isolation of porcine and human PCs was performed by the treatment of adipose tissue with collagenase, washing steps and a density gradient centrifugation. The characterization of the cells occurred by antibody staining (factor XIII, collagenase IV, tropomyosine). The osteogene and adipogene differentiation succeeded by the treatment with special cultivation media. Results: We have isolated adipose tissue PCs and differentiated them in adipocytes and osteoblasts. The definite differentiation towards two different cell types proves the pluripotence of this cell type. In the adipose tissue the PCs are arranged around blood vessels. The antibody stain against endothelial cells did not succeed in vitro, which proved, that the isolated PCs are in vivo ""adipose tissue pericytes"". Perspective: The long-term aim is to build up a three-dimensional test system with these cells. Ideally it should be a vascularized test system to be able to calculate risks in an overarching way. Such a vascularised test system regarding the liver was developed at Fraunhofer IGB.
Author(s)
Drescher, S.
Linke, K.  
Mertsching, H.  
Mainwork
44th Congress of the European Societies of Toxicology, EUROTOX 2007. Abstracts  
Conference
European Societies of Toxicology (Congress) 2007  
DOI
10.1016/j.toxlet.2007.05.573
Language
English
Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024